Generation of anti-hirudin antibodies in heparin-induced thrombocytopenic patients treated with r-hirudin

Circulation

Volumn 100, Issue 14, 1999, Pages 1528-1532

  Song, Xuehong ^b   Huhle, Günter ^b   Wang, Lianchun ^b   Hoffmann, Ursula ^b   Harenberg, Job ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b NONE

Author keywords

Antibodies; Anticoagulants; Proteins; Thrombosis

Indexed keywords

HEPARIN; LEPIRUDIN; PROTEIN ANTIBODY;

ADULT; AGED; ANTIBODY PRODUCTION; ANTICOAGULANT THERAPY; ARTICLE; CLINICAL ARTICLE; DRUG INDUCED DISEASE; HUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; THROMBOCYTOPENIA;

EID: 0033527370     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.100.14.1528     Document Type: Article

References (17)

1. Markwardt F. The development of hirudin as an antithrombotic drug. Thromb Res. 1994;74:1-23.
2. Eriksson BI, Wille-Jorgensen P, Kalebo P, Mouret P, Rosencher N, Bosch P, Baur M, Ekman S, Bach D, Lindbratt S, Close P. A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement. N Engl J Med. 1997;337:1329-1335.
3. White HD, Aylward PE, Frey MJ, Adgey AAJ, Nair R, Hillis WS, Shaler Y, Brown MA, French JK, Collins R, Maraganore J, Adelman B. Randomized, double-blind comparison of hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO). Circulation. 1997;96:2155-2161.
4. Organization to Assess Strategies for Ischemic Syndromes (OASIS) Investigators. Comparison of the effects of two doses of recombinant hirudin compared with heparin in patients with acute myocardial ischemia without ST elevation: a pilot study. Circulation. 1997;96:769-777.
5. Schiele F, Vuillemenot A, Kramarz P, Kieffer Y, Soria J, Soria C, Camez A, Mirshahi MC, Bassand JP. A pilot study of subcutaneous recombinant hirudin (HBW 023) in the treatment of deep vein thrombosis. Thromb Haemost. 1994;71:558-562.
6. Greinacher A, Völpel H, Janssens U, Hach-Wunderle V, Kemkes-Matthes B, Eichler P, Mueller-Velten HG, Pötzsch B. Recombinant hirudin (Lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study. Circulation. 1999;99:73-80.
7. Harenberg J, Huhle G, Piazolo L, Wang LC, Heene DL. Anticoagulation in patients with heparin-induced thrombocytopenia. Semin Thromb Hemost. 1997;23:189-216.
8. Bichler J, Gemmerli R, Fritz H. Studies for revealing a possible sensitization to hirudin after repeated intra-venous injection in baboons. Thromb Res. 1991;61:39-51.
9. Close P, Bichler J, Kerry R, Ekmann S, Bueller HR, Kienast J, Marbet GA, Schramm W, Verstraete M. Weak allergenicity of recombinant hirudin CGP39393 (REVASC) in immunocompetent volunteers. Coron Artery Dis. 1994;5:943-949.
10. Sheridan D, Carter C, Kelton JG. A diagnostic test for heparin-induced thrombocytopenia. Blood. 1986;67:27-30.
11. Greinacher A, Michels I, Kiefel V, Mueller-Eckhardt C. A rapid and sensitive test for diagnosing heparin-associated thrombocytopenia. Thromb Haemost. 1991;66:734-736.
12. Newman PM, Swanson RL, Chong BH. Heparin-induced thrombocytopenia: IgG binding to PF4-heparin complexes in the fluid phase and cross-reactivity with low molecular weight heparin and heparinoid. Thromb Haemost. 1998;80:292-297.
13. Wang LC, Huhle G, Maisch R, Hoffmann U, Song XH, Harenberg J. Determination of heparin-induced IgG antibody by fluorescence-linked immunofiltration assay (FLIFA). J Immunol Methods. 1999;222:93-99.
14. Kemeny DM. A Practical Guide to ELISA. Oxford: Pergamon Press; 1991.
15. Nowak G, Bucha E. Quantitative determination of hirudin in blood and body fluids. Semin Thromb Hemost. 1996;22:197-202.
16. Song XH, Wang LC, Huhle G, Harenberg J. Determination of PEG-hirudin in human and rat plasma by competitive ELISA. Ann Hematol. 1998;76(suppl I):133. Abstract.
17. Eichler P, Greinacher A. Anti-hirudin antibodies induced by recombinant hirudin in the treatment of patients with heparin-induced thrombocytopenia (HIT). Ann Hematol. 1996;72(suppl I):21. Abstract.